Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


3 Ann Oncol
3 Ann Surg Oncol
2 Anticancer Res
6 BMC Cancer
1 Br J Cancer
2 Breast Cancer (Dove Med Press)
5 Breast Cancer Res
5 Breast Cancer Res Treat
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
2 Clin Breast Cancer
3 Clin Cancer Res
2 Eur J Surg Oncol
1 Gene
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Natl Cancer Inst
1 J Nucl Med
1 Lancet Oncol
2 Oncogene
1 Oncology
3 PLoS Comput Biol
2 PLoS Genet
4 PLoS One

    Ann Oncol

  1. BRUSSELAERS N, Tamimi RM, Konings P, Rosner B, et al
    Different menopausal hormone regimens and risk of breast cancer.
    Ann Oncol. 2018 Jun 18. pii: 5039890. doi: 10.1093.
    >> Share

  2. DIOSSY M, Reiniger L, Sztupinszki Z, Krzystanek M, et al
    Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors.
    Ann Oncol. 2018 Jun 18. pii: 5039891. doi: 10.1093.
    >> Share

  3. ZHANG J, Lin Y, Sun XJ, Wang BY, et al
    Biomarker assessment of the CBCSG006 trial: A randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer.
    Ann Oncol. 2018 Jun 14. pii: 5037891. doi: 10.1093.
    >> Share

    Ann Surg Oncol

  4. BAZAN JG, Majithia L, Quick AM, Wobb JL, et al
    Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates.
    Ann Surg Oncol. 2018 Jun 18. pii: 10.1245/s10434-018-6565.
    >> Share

  5. ALTMAN AM, Kizy S, Yuan J, Denbo JW, et al
    Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States.
    Ann Surg Oncol. 2018 Jun 15. pii: 10.1245/s10434-018-6566.
    >> Share

  6. SHAH C, Al-Hilli Z, Schwarz G
    Oncoplastic Surgery in Breast Cancer: Don't Forget the Boost!
    Ann Surg Oncol. 2018 Jun 15. pii: 10.1245/s10434-018-6571.
    >> Share

    Anticancer Res

  7. RUSAK A, Jablonska K, Piotrowska A, Grzegrzolka J, et al
    The Role of CHI3L1 Expression in Angiogenesis in Invasive Ductal Breast Carcinoma.
    Anticancer Res. 2018;38:3357-3366.
    >> Share

  8. ASANO M, Matsui J, Towle MJ, Wu J, et al
    Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven(R)): Combination with Anticancer Agents of Differing Mechanisms.
    Anticancer Res. 2018;38:3375-3385.
    >> Share

    BMC Cancer

  9. INOUE K, Ninomiya J, Saito T, Kimizuka K, et al
    Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 3
    BMC Cancer. 2018;18:671.
    >> Share

  10. LI Y, Du Y, Sun T, Xue H, et al
    PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model.
    BMC Cancer. 2018;18:669.
    >> Share

  11. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
    Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
    BMC Cancer. 2017;17:741.
    >> Share

  12. LOFTEROD T, Mortensen ES, Nalwoga H, Wilsgaard T, et al
    Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
    BMC Cancer. 2018;18:654.
    >> Share

  13. XU H, Xu Y, Ouyang T, Li J, et al
    Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.
    BMC Cancer. 2018;18:662.
    >> Share

  14. LI R, Xiao C, Liu H, Huang Y, et al
    Effects of local anesthetics on breast cancer cell viability and migration.
    BMC Cancer. 2018;18:666.
    >> Share

    Br J Cancer

  15. LO LL, Milne RL, Liao Y, Cuzick J, et al
    Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.
    Br J Cancer. 2018 Jun 21. pii: 10.1038/s41416-018-0120.
    >> Share

    Breast Cancer (Dove Med Press)

  16. COOK MT
    Mechanism of metastasis suppression by luteolin in breast cancer.
    Breast Cancer (Dove Med Press). 2018;10:89-100.
    >> Share

  17. BUTTI R, Kumar TV, Nimma R, Kundu GC, et al
    Impact of semaphorin expression on prognostic characteristics in breast cancer.
    Breast Cancer (Dove Med Press). 2018;10:79-88.
    >> Share

    Breast Cancer Res

  18. LIM KT, Cosgrave N, Hill AD, Young LS, et al
    Correction to: Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1.
    Breast Cancer Res. 2018;20:61.
    >> Share

  19. SUROV A, Clauser P, Chang YW, Li L, et al
    Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.
    Breast Cancer Res. 2018;20:58.
    >> Share

  20. DONZELLI S, Milano E, Pruszko M, Sacconi A, et al
    Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
    Breast Cancer Res. 2018;20:59.
    >> Share

  21. ALVES CL, Elias D, Lyng MB, Bak M, et al
    SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
    Breast Cancer Res. 2018;20:60.
    >> Share

  22. LEWIS-WAMBI JS, Kim HR, Wambi C, Patel R, et al
    Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Breast Cancer Res. 2018;20:57.
    >> Share

    Breast Cancer Res Treat

  23. KOGAWA T, Fujii T, Fouad TM, Liu DD, et al
    Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
    Breast Cancer Res Treat. 2018 Jun 18. pii: 10.1007/s10549-018-4853.
    >> Share

  24. JERZAK KJ, Cockburn JG, Dhesy-Thind SK, Pond GR, et al
    Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study.
    Breast Cancer Res Treat. 2018 Jun 18. pii: 10.1007/s10549-018-4844.
    >> Share

  25. MARTIN M, de la Torre-Montero JC, Lopez-Tarruella S, Pinilla K, et al
    Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.
    Breast Cancer Res Treat. 2018 Jun 19. pii: 10.1007/s10549-018-4855.
    >> Share

  26. YAP YS, Munusamy P, Lim C, Chan CHT, et al
    Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
    Breast Cancer Res Treat. 2018 Jun 21. pii: 10.1007/s10549-018-4851.
    >> Share

  27. PEREIRA PTVT, Reis AD, Diniz RR, Lima FA, et al
    Dietary supplements and fatigue in patients with breast cancer: a systematic review.
    Breast Cancer Res Treat. 2018 Jun 18. pii: 10.1007/s10549-018-4857.
    >> Share


  28. PRINTZ C
    Older women with a family history of breast cancer face increased risk of the disease.
    Cancer. 2018;124:2673.
    >> Share

    Cancer Chemother Pharmacol

  29. XU C, Ravva P, Dang JS, Laurent J, et al
    A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel.
    Cancer Chemother Pharmacol. 2018 Jun 18. pii: 10.1007/s00280-018-3621.
    >> Share

    Cancer Epidemiol Biomarkers Prev

  30. HJERKIND KV, Ellingjord-Dale M, Johansson ALV, Aase HS, et al
    Volumetric mammographic density, age-related decline, and breast cancer risk factors in a national breast cancer screening program.
    Cancer Epidemiol Biomarkers Prev. 2018 Jun 20. pii: 1055-9965.EPI-18-0151.
    >> Share

    Cancer Res

  31. Correction: TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.
    Cancer Res. 2018;78:3403.
    >> Share

    Clin Breast Cancer

  32. CHEN J, Wu X, Christos P, Yan W, et al
    Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(17)30641.
    >> Share

  33. KIM HJ, Kang E, Kim JH, Kim SH, et al
    Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2018 May 28. pii: S1526-8209(18)30104.
    >> Share

    Clin Cancer Res

  34. PARK H, Lim Y, Ko ES, Cho HH, et al
    Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer.
    Clin Cancer Res. 2018 Jun 18. pii: 1078-0432.CCR-17-3783.
    >> Share

  35. SHEN H, Mu C, Wu X, Zhou X, et al
    Chemotherapy sensitizes therapy-resistant cells to mild hyperthermia by suppressing heat shock protein 27 expression in triple negative breast cancer.
    Clin Cancer Res. 2018 Jun 19. pii: 1078-0432.CCR-17-3872.
    >> Share

  36. CUI Y, Li B, Pollom EL, Horst K, et al
    Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
    Clin Cancer Res. 2018 Jun 19. pii: 1078-0432.CCR-18-0825.
    >> Share

    Eur J Surg Oncol

  37. HASSING CMS, Tvedskov TF, Kroman N, Klausen TL, et al
    Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.
    Eur J Surg Oncol. 2018;44:725-730.
    >> Share

  38. MYLVAGANAM S, Conroy EJ, Williamson PR, Barnes NLP, et al
    Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.
    Eur J Surg Oncol. 2018;44:708-716.
    >> Share


  39. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    >> Share

    Int J Cancer

  40. LIPTON A, Leitzel K, Ali SM, Polimera HV, et al
    High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
    Int J Cancer. 2018 Jun 20. doi: 10.1002/ijc.31627.
    >> Share

    Int J Radiat Oncol Biol Phys

  41. STECKLEIN SR, Park M, Liu DD, Valle Goffin JJ, et al
    Long-Term Impact of Regional Nodal Irradiation in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 18. pii: S0360-3016(18)31007.
    >> Share

    J Natl Cancer Inst

  42. Corrigendum to "Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer".
    J Natl Cancer Inst. 2018;110:684.
    >> Share

    J Nucl Med

  43. KURLAND BF, Oesterreich S
    Heterogeneity in metastatic breast cancer (18)F-fluoroestradiol uptake - clinically actionable, biologically illuminating?
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.214304. doi: 10.2967/jnumed.118.214304.
    >> Share

    Lancet Oncol

  44. BURKI TK
    Variations in breast cancer treatment and outcomes.
    Lancet Oncol. 2018 Jun 14. pii: S1470-2045(18)30451.
    >> Share


  45. LEE S, Axelsen TV, Jessen N, Pedersen SF, et al
    Na(+),HCO3(-)-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.
    Oncogene. 2018 Jun 15. pii: 10.1038/s41388-018-0353.
    >> Share

  46. BROUGH R, Gulati A, Haider S, Kumar R, et al
    Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer.
    Oncogene. 2018 Jun 18. pii: 10.1038/s41388-018-0368.
    >> Share


  47. BAE SY, Jung SP, Jung ES, Park SM, et al
    Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Oncology. 2018 Jun 18:1-7. doi: 10.1159/000488944.
    >> Share

    PLoS Comput Biol

  48. SUN JX, He Y, Sanford E, Montesion M, et al
    A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    PLoS Comput Biol. 2018;14:e1005965.
    >> Share

  49. ENGEL M, Longden J, Ferkinghoff-Borg J, Robin X, et al
    Bowhead: Bayesian modelling of cell velocity during concerted cell migration.
    PLoS Comput Biol. 2018;14:e1005900.
    >> Share

  50. SHIN SY, Muller AK, Verma N, Lev S, et al
    Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
    PLoS Comput Biol. 2018;14:e1006192.
    >> Share

    PLoS Genet

  51. HOLLERN DP, Swiatnicki MR, Andrechek ER
    Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.
    PLoS Genet. 2018;14:e1007135.
    >> Share

  52. PAULO P, Maia S, Pinto C, Pinto P, et al
    Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
    PLoS Genet. 2018;14:e1007355.
    >> Share

    PLoS One

  53. MCDONNELL SL, Baggerly CA, French CB, Baggerly LL, et al
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    PLoS One. 2018;13:e0199265.
    >> Share

  54. HENRY TR, Marshall SA, Avis NE, Levine BJ, et al
    Concordance networks and application to clustering cancer symptomology.
    PLoS One. 2018;13:e0191981.
    >> Share

  55. ALI S, Malik MZ, Singh SS, Chirom K, et al
    Exploring novel key regulators in breast cancer network.
    PLoS One. 2018;13:e0198525.
    >> Share

  56. EASTLACK SC, Dong S, Mo YY, Alahari SK, et al
    Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
    PLoS One. 2018;13:e0198945.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016